Sudo raises $116M to develop TYK2 inhibitors for MS, other diseases
Biopharmaceutical plans to advance 2 candidates into clinical trials in 2024 by Patricia Inacio, PhD | January 2, 2024 Sudo…
AI Algorithm May Predict Medication Adherence in Patients with MS
September 22, 2023 Rosanna Sutherby, Pharm.D. woop, a New York-based company, has launched an algorithm that may help people with…
Stuart Schlossman
BTK Inhibitor Reduces Brain Lesions in Relapsing MS
— Subgroup analysis shows brain penetration by Judy George, Deputy Managing Editor, MedPage Today October 19, 2023 Share on Facebook. Opens…
Stuart Schlossman
Risky movement: Assessing fall risk in people with multiple sclerosis with wearable sensors and beacon-based smart-home monitoring
PubMed: https://pubmed.ncbi.nlm.nih.gov/37801954/ Abstract Background: People with multiple sclerosis (PwMS) fall frequently causing injury, social isolation, and decreased quality of life. Identifying locations…
Stuart Schlossman
Multiple Sclerosis DMT Waste Is STARTLING, New Study Shows (View the photo with the waste build-up)
June 22, 2022 — by: Alicia Bigica More than $5.2 million in new, unused DMTs were collected from patients with…
Stuart Schlossman
Behavioral Training May Help MS Patients Recognize Facial Expressions
April 14, 2022 An intervention that involves training to recognize facial expressions, and also mimicking these expressions, may help people…
Stuart Schlossman
The Status of NMOSD Patient Education and the Development Pipeline
August 28, 2021 – Matt Hoffman Bruce Cree, MD, PhD, clinical research director of the UCSF Multiple Sclerosis Center, provided…
Stuart Schlossman
The complex situation for immunocompromised people and COVID-19 vaccines
PHOTOGRAPH BY FEDERICO PARRA, AFP VIA GETTY IMAGES For those with compromised immune systems, receiving the COVID-19 vaccine…
Stuart Schlossman
New study shines light on causes of dementia
By JULIAN SHEA in London | China Daily Global | Updated: 2021-03-15 04:55A new study led by the University of…
Stuart Schlossman
JDRF, Lupus Research Alliance, and National MS Society Join Forces to Decode Common Mechanisms of Immune-Mediated Diseases
Click HERE to Subscribe for the MS Beacon Newsletter February 24, 2021 — First Joint Common Mechanisms Grants Announced JDRF International,…
Stuart Schlossman
